Characteristics | Intervention (n = 101) | Control (n = 99) | p |
---|---|---|---|
Male - n (%) | 70 (69) | 70 (71) | 0.83 |
Age (years)a | 60.4 ± 9.1 | 59.6 ± 10.4 | 0.55 |
Education (years)b | 5.0 (4–11) | 6.0 (4–11) | 0.91 |
Type of coronary angioplasty – n (%) | |||
Balloon | 6 (5.9) | 3 (3.1) | 0.32 |
Conventional stent | 88 (87.2) | 83 (83.8) | 0.51 |
Pharmacological stent | 7 (6.9) | 13 (13.1) | 0.14 |
Clinical history- n (%) | |||
Systemic arterial hypertension | 83 (82.2) | 88 (88.9) | 0.18 |
Dyslipidaemia | 70 (69.3) | 82 (82.8) | 0.03 |
Type 2 diabetes | 41 (40.6) | 36 (36.4) | 0.54 |
Family history of premature coronary heart disease | 45 (44.6) | 34 (34.3) | 0.14 |
Previous acute myocardial infarction | 44 (43.6) | 42 (42.4) | 0.87 |
Previous angioplasty | 19 (18.8) | 24 (24.2) | 0.35 |
Heart surgery | 9 (8.9) | 13 (13.1) | 0.34 |
Smoking status – n (%) | |||
Non-smoker | 64 (63.4) | 61 (61.6) | 0.30 |
Former smoker | 13 (12.9) | 20 (20.2) | |
Smoker | 24 (23.8) | 18 (18.2) | |
Medication use – n (%) | |||
Antihypertensive agents | 73 (72.3) | 82 (82.8) | 0.07 |
Oral hypoglycaemic agents | 32 (31.7) | 23 (23.2) | 0.18 |
Statins | 50 (49.5) | 57 (57.6) | 0.25 |
Antiarrhythmic agents | 59 (58.4) | 63 (63.6) | 0.45 |